239,306
Participants
Start Date
May 17, 2018
Primary Completion Date
December 31, 2018
Study Completion Date
December 31, 2018
Fluoroquinolone (FQ)
Participants exposed to an oral FQ will be observed. The oral FQ included are Levofloxacin, Ciprofloxacin, Moxifloxacin, Ofloxacin, Gemifloxacin. Participants will not receive any intervention as a part of this study.
Azithromycin (AZ)
Participants exposed to an oral AZ will be observed. Participants will not receive any intervention as a part of this study.
Sulfamethoxazole/Trimethoprim (ST) Fixed Dose Combination
Participants exposed to an oral ST will be observed. Participants will not receive any intervention as a part of this study.
Janssen Investigative Site, Titusville
Janssen Research & Development, LLC
INDUSTRY